BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 26843134)

  • 1. MicroRNA-26b Enhances the Radiosensitivity of Hepatocellular Carcinoma Cells by Targeting EphA2.
    Jin Q; Li XJ; Cao PG
    Tohoku J Exp Med; 2016 Feb; 238(2):143-51. PubMed ID: 26843134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2.
    Jin Q; Li XJ; Cao PG
    Iran J Basic Med Sci; 2016 Aug; 19(8):851-857. PubMed ID: 27746866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-10b-5p Suppresses the Proliferation and Invasion of Primary Hepatic Carcinoma Cells by Downregulating EphA2.
    Niu X; Sun H; Qiu F; Liu J; Yang T; Han W
    Biomed Res Int; 2021; 2021():1382061. PubMed ID: 35005012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy.
    Chen E; Li E; Liu H; Zhou Y; Wen L; Wang J; Wang Y; Ye L; Liang T
    Int J Biol Sci; 2021; 17(3):781-795. PubMed ID: 33767588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling.
    Wang H; Hou W; Perera A; Bettler C; Beach JR; Ding X; Li J; Denning MF; Dhanarajan A; Cotler SJ; Joyce C; Yin J; Ahmed F; Roberts LR; Qiu W
    Cell Rep; 2021 Feb; 34(8):108765. PubMed ID: 33626345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of miR-661 inhibits the metastasis of hepatocellular carcinoma.
    Wang J; Yu Z; Ma H; Zhang G
    Asian J Surg; 2024 May; 47(5):2491-2493. PubMed ID: 38281832
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation.
    Meng C; Liu Y; Shen Y; Liu S; Wang Z; Ye Q; Liu H; Liu X; Jia L
    Oncol Lett; 2018 Feb; 15(2):1435-1440. PubMed ID: 29399189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA MALAT1 protects against Aβ
    Chanda K; Jana NR; Mukhopadhyay D
    Life Sci; 2022 Aug; 302():120652. PubMed ID: 35598655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 as a phase separation protein associated with ferroptosis and immune cell infiltration in colorectal cancer.
    Li Y; Peng Q; Wang L
    Aging (Albany NY); 2023 Nov; 15(22):12952-12965. PubMed ID: 37980165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic miRNA Screen Identifies miR-26b to Promote the Growth and Survival of Endothelial Cells.
    Martello A; Mellis D; Meloni M; Howarth A; Ebner D; Caporali A; Al Haj Zen A
    Mol Ther Nucleic Acids; 2018 Dec; 13():29-43. PubMed ID: 30227275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin: Erratum.
    Anticancer Drugs; 2024 Mar; 35(3):316. PubMed ID: 38411026
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of EphA2 is associated with apoptosis in response to H
    Zhao W; Chen S; Lu B; Wu D; Gu Y; Hao S; Sheng F; Xu Y; Han Y; Chen R; Zhou L; Fu Q; Yao K
    Arch Biochem Biophys; 2023 Oct; 747():109756. PubMed ID: 37714253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting EphA2: a promising strategy to overcome chemoresistance and drug resistance in cancer.
    Veiga RN; de Azevedo ALK; de Oliveira JC; Gradia DF
    J Mol Med (Berl); 2024 Apr; 102(4):479-493. PubMed ID: 38393661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
    Zhou Y; Liu F; Ma C; Cheng Q
    J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer.
    Nguyen L; Schilling D; Dobiasch S; Raulefs S; Santiago Franco M; Buschmann D; Pfaffl MW; Schmid TE; Combs SE
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33317198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications.
    Hughes RM; Virag JAI
    Pharmaceuticals (Basel); 2020 Jun; 13(6):. PubMed ID: 32492868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To construct a ceRNA regulatory network as prognostic biomarkers for bladder cancer.
    Jiang J; Bi Y; Liu XP; Yu D; Yan X; Yao J; Liu T; Li S
    J Cell Mol Med; 2020 May; 24(9):5375-5386. PubMed ID: 32233022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of Hepatocellular Carcinoma through Targeting Radio-Associated MicroRNA.
    Wu CH; Chen CY; Yeh CT; Lin KH
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mir-26b inhibits growth and resistance to paclitaxel chemotherapy by silencing the CDC6 gene in gastric cancer.
    Zhao B; Zhang J; Chen X; Xu H; Huang B
    Arch Med Sci; 2019 Mar; 15(2):498-503. PubMed ID: 30899303
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.